• Science & Technology
• Health & Medicine

Cancer waiting time targets – simply not good enough

Today's new cancer waiting time data are the worst since records began, and paint a gloomy picture of deteriorating cancer services. We take a closer look. Today's new cancer waiting time data are the worst since records began, and paint a gloomy picture of deteriorating cancer services. We take a closer look.

20 May 2015

• Health & Medicine

Many hands make light work – the evolution of clinical trials

For International Clinical Trials Day 2015 we look at how trials have changed - from the first recorded trial to today's modern cancer clinical trials. For International Clinical Trials Day 2015 we look at how trials have changed - from the first recorded trial to today's modern cancer clinical trials.

20 May 2015

• Health & Medicine

Chemo before surgery benefits patients with advanced ovarian cancer

Women with advanced ovarian cancer have fewer side effects and tend to have a better quality of life if given chemotherapy before surgery Women with advanced ovarian cancer have fewer side effects and tend to have a better quality of life if given chemotherapy before surgery

20 May 2015

• Science & Technology
• Health & Medicine

Dame Sally Davies: ‘We can make research a statement, not a question’

19 May 2015

• Health & Medicine

How to make the NHS a research powerhouse

Our new report, Every Patient a Research Patient? looks at how well the NHS is performing at offering cancer patients the opportunity to take part in research. Our new report, Every Patient a Research Patient? looks at how well the NHS is performing at offering cancer patients the opportunity to take part in research.

19 May 2015

• Science & Technology

NHS pressures at risk of stifling cancer research

Daily pressures on the NHS are having a serious impact on its ability to support world leading research into cancer. Daily pressures on the NHS are having a serious impact on its ability to support world leading research into cancer.

19 May 2015

• Science & Technology

Proposed cuts to Europe’s research budget – why we’re fighting back

We explain why a set of proposed cuts to the European research budget could be bad news for the UK research scene. We explain why a set of proposed cuts to the European research budget could be bad news for the UK research scene.

18 May 2015

• Health & Medicine

Worried about sunscreen? The 3 key ways to avoid sunburn this summer

As a new report suggests not all sunscreens do what they say on the bottle, we look at the best ways to enjoy the sun safely As a new report suggests not all sunscreens do what they say on the bottle, we look at the best ways to enjoy the sun safely

18 May 2015

• Science & Technology
• Health & Medicine

News digest - prostate cancer chemo, Cuban lung cancer vaccine treatment and ... walnuts?

Find out about a new prostate cancer treatment, the Cuban lung cancer vaccine and if a handful of Walnuts can make cancer go away. Find out about a new prostate cancer treatment, the Cuban lung cancer vaccine and if a handful of Walnuts can make cancer go away.

16 May 2015

• Science & Technology
• Health & Medicine

Don’t take vitamin B3 to prevent skin cancer - stick with shade

This morning's headlines about vitamin B3 and skin cancer were a little over the top. Here are our thoughts on the research behind the story This morning's headlines about vitamin B3 and skin cancer were a little over the top. Here are our thoughts on the research behind the story

15 May 2015

• Health & Medicine
• Science & Technology

Election 2015: What does the result mean for cancer?

As the dust settles on an unexpected election result, we look at what the UK’s new political landscape means for political action against cancer. As the dust settles on an unexpected election result, we look at what the UK’s new political landscape means for political action against cancer.

13 May 2015

• Science & Technology
• Health & Medicine

When defences attack: the hidden cause of cancer hiding in our cells

We look at APOBECs - biological double-agents that start out as a friend to our cells but morph into a deadly enemy as cancers develop. We look at APOBECs - biological double-agents that start out as a friend to our cells but morph into a deadly enemy as cancers develop.

12 May 2015